Dr. Susan Zweizig, MD
Claim this profileUniversity of Massachusetts
Studies Ovarian Cancer
Studies Ovarian Tumors
11 reported clinical trials
22 drugs studied
Area of expertise
1Ovarian Cancer
Stage III
Stage IV
Stage II
2Ovarian Tumors
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Susan Zweizig, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Susan Zweizig, MD
Clinical Trial Related4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Susan Zweizig, MD has experience with
- Paclitaxel
- Letrozole
- Pembrolizumab
- Carboplatin
- Afuresertib
- Abemaciclib
Breakdown of trials Susan Zweizig, MD has run
Ovarian Cancer
Ovarian Tumors
Adenocarcinoma
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susan Zweizig, MD specialize in?
Susan Zweizig, MD focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are Stage IV.
Is Susan Zweizig, MD currently recruiting for clinical trials?
Yes, Susan Zweizig, MD is currently recruiting for 3 clinical trials in Worcester Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Susan Zweizig, MD has studied deeply?
Yes, Susan Zweizig, MD has studied treatments such as Paclitaxel, Letrozole, Pembrolizumab.
What is the best way to schedule an appointment with Susan Zweizig, MD?
Apply for one of the trials that Susan Zweizig, MD is conducting.
What is the office address of Susan Zweizig, MD?
The office of Susan Zweizig, MD is located at: University of Massachusetts, Worcester, Massachusetts 01605 United States. This is the address for their practice at the University of Massachusetts.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.